Jul 2026
Identification of a prognostic signature based on expression of post-translational modification-related genes in acute myeloid leukemia.
This PTM-associated signature accurately stratifies AML patients and reveals immune microenvironment disparities, enabling precise personalized prognosis and identifies PTM-related genes as promising therapeutic targets for AML immunotherapy.
D. Gan, Jin-fang Zeng, Jun Lin et al.
· Japanese Journal of Clinical... · 0 citations